Equity · Technology
G
NYSEGenpact (G)
The line runs 34.95 USD on 17 September through 40.83 USD on 23 October, on a scale from 30 to 45. Days the market did not trade hold the previous close, flat.
- Market cap
- 6.8B USD
- P/E (TTM)
- 11.9
- Revenue, year to Dec 2025
- 5.1B USD
- EPS, diluted, year to Dec 2025
- 3.13 USD
- 52-week range
- 27.52 USD – 48.53 USD
- Avg volume
- 157.3K
as of Oct 23, 2026
Have Genpact (G) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Genpact insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 10 Oct 2025, show no open-market purchase.
Form 4, 90 days to 10 Nov 2026, newest reported trade 14 Sep 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 14 Sep 2026 | Kalra BalkrishanPresident and CEO | Sell | 10,000 | 368K USD |
| 19 Aug 2026 | Nanduru AnilSenior Vice President | Sell | 6,191 | 229K USD |
| 14 Aug 2026 | Dewan SameerSenior Vice President | Sell | 14,972 | 511K USD |
| 13 Aug 2026 | Weiner Michael HalChief Financial Officer | Sell | 5,900 | 201K USD |
| 12 Aug 2026 | Nanduru AnilSenior Vice President | Sell | 11,852 | 402K USD |
| Sold | 5 open-market sales | 48,915 | $1.71M |
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 09 Sep 2026 | Pandit SumitaChief Financial Officer | Award | 76,713 |
Which funds hold Genpact (G)?
9 of the 45 institutional funds we track reported a Genpact position for the quarter ended 30 Jun 2026 — a combined 480.7M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Held (±25%) | 8,601,538 | 232.8M USD | −23.7% |
| Citadel Advisors | Added | 2,478,939 | 68.2M USD | +2,109.4% |
| Millennium Management | Added | 1,912,916 | 52.6M USD | +139.5% |
| Two Sigma Investments | Added | 1,632,071 | 44.9M USD | +1,367.5% |
| Marshall Wace | Added | 1,141,985 | 31.4M USD | +13,333.5% |
| D. E. Shaw & Co. | Held (±25%) | 786,388 | 21.6M USD | −9.4% |
| Balyasny Asset Management | Held (±25%) | 380,006 | 10.5M USD | +10.4% |
| Man Group | Held (±25%) | 351,426 | 9.7M USD | −14.3% |
| Tudor Investment Corp | New position | 328,285 | 9.0M USD | |
| Bridgewater Associates | Exited |
What has been filed or recorded for Genpact (G)?
The filings we hold for Genpact, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 6,502 shares | 229K USD notional · 0.004% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 0.89 USD | |
| 30 Sep 2026 | Financials | Total assets | 5.6B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 2.7B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 0.86 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.86 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 3.13 USD | |
| 31 Dec 2025 | Financials | Revenue | 5.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 552.5M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 3.13 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.83 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.75 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.73 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 2.85 USD |
What do people ask about Genpact (G)?
What did Genpact shares close at?40.83
Genpact closed at 40.83 USD on 23 Oct 2026, down 2.79% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Genpact’s market cap?6.8B
Genpact is worth 6.8B USD by market value as of 23 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Genpact’s P/E ratio?11.9
Genpact has a price-to-earnings ratio of 11.9, as of 23 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Genpact’s revenue?5.1B
Genpact reported revenue of 5.1B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Genpact insiders bought or sold shares recently?5 sales
In the 90 days to 10 Nov 2026, Genpact insiders reported 5 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 10 Oct 2025, show no open-market purchase. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders
Which funds own Genpact?9 of 45
9 of the 45 funds we track reported a Genpact position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Citadel Advisors and Millennium Management. See Funds
When did Genpact last report earnings?0.89
Genpact last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 0.89 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings